Basic Information
Basic information for AC022034.3-216-12aa
Peptide Name AC022034.3-216-12aa
Genome Position chr8:53395218-53395253[-]
Species Human
Peptide Sequence MSRRPLHSGQAL
Peptide Length 12
Unique No (AC022034.3-219-12aa,AC022034.3-212-12aa,AC022034.3-202-12aa,AC022034.3-222-12aa,AC022034.3-206-12aa,AC022034.3-204-12aa,AC022034.3-217-12aa,AC022034.3-210-12aa,AC022034.3-211-12aa,AC022034.3-214-12aa,AC022034.3-221-12aa,AC022034.3-203-12aa,AC022034.3-209-12aa,AC022034.3-205-12aa,AC022034.3-213-12aa,AC022034.3-207-12aa,AC022034.3-201-12aa,AC022034.3-215-12aa,AC022034.3-218-12aa,AC022034.3-220-12aa,AC022034.3-208-12aa)
Grand Average of Hydropathicity -0.6667
Relative Molecular Mass 1550.73
Experimental Evidences no
lncRNA ID/Name ENSG00000253369;AC022034.3
Transcript ID/Name ENST00000670087;AC022034.3-216
Transcript Length 1301
Coding Ability 0.3966
DNA Sequence Corresponding to Peptide ATGTCTAGGAGACCTCTTCACTCAGGGCAAGCTCTA
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :